By Justin Caba | May 17, 2013 04:46 PM EDT
Tweleve-year-old Cristian Beasley got the surprise of his life this week when a NFL star J.J. Watt stopped by to visit.
By Susan Scutti | May 16, 2013 02:07 PM EDT
The biopharmaceutical company, which operates in over 100 countries, has issued an update on its oncology pipeline for 2013.
By Christie Rizk | May 10, 2013 12:15 AM EDT
Researchers use small doses of a leukemia drug to treat neurodegenerative diseases in a new study.
By Anthony Rivas | May 03, 2013 12:11 AM EDT
Two new studies released on Wednesday reported genetic links deep within the DNA cells of Leaukemia and Endometrial Cancer.
By Evan Winchester | Apr 26, 2013 04:10 PM EDT
Doctors and experts are claiming that leukemia patients are being held hostage by the exorbitant price tags of cancer drugs like Gleevac.
By Ansa Varughese | Apr 24, 2013 09:33 AM EDT
Cameron Lyle, 21, a shot put athlete from University of New Hampshire put the America East Championships on hold to donate his bone marrow to a leukemia patient given six months to live.
By Makini Brice | Dec 10, 2012 04:50 PM EST
The treatment uses a disabled version of the virus that causes AIDS to reprogram the genes of a person’s immune system and retrain it to kill cancer cells.
By Makini Brice | Nov 26, 2012 03:50 PM EST
Mykayla Comstock is one of 52 children who are enrolled in the Oregon Medical Marijuana program, which is open to children who have an approved medical condition and approval from parents and doctors.
By Christine Hsu | Nov 07, 2012 04:46 PM EST
When locals living in a small Colorado community heard the heart-wrenching story of Alex, a nine-year-old boy who was dying from leukemia, they wanted to help.
By Christine Hsu | Oct 18, 2012 12:13 PM EDT
The longer babies are fed formula, the greater their risk for pediatric acute lymphoblastic leukemia.
By Makini Brice | Sep 21, 2012 11:08 AM EDT
The University of Texas M.D. Anderson Cancer Center has launched a program that seeks to dramatically reduce the death rates of eight deadly and common cancers.
By Anna Yukhananov | Sep 05, 2012 09:34 AM EDT
Health regulators on Tuesday approved a Pfizer Inc pill for a rare type of leukemia, another step in the company's effort to expand its oncology business.
